abstract |
The present invention is a therapeutic agent for preventing and / or treating cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, heart and vascular diseases and metabolic diseases. Of Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Gln-Phe-Lys-Val-Val-Thr-OH. Further, the present invention provides a peptide of Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Gln-Phe-Lys-Val-Val-Thr-OH and optionally at least one pharmaceutically acceptable Comprising a carrier, at least one cryoprotectant, at least one dispersion protectant, at least one excipient and / or at least one diluent, preferably lyophilizate, buffer, artificial breast milk formulation, or It relates to a pharmaceutical composition in the form of a breast milk substitute. |